Bioengineer Gang Bao uses gene editing to repair up to 40 percent of bone marrow cells from patients
Scientists have successfully used gene editing to repair 20 to 40 percent of stem and progenitor cells taken from the peripheral blood of patients with sickle cell disease, according to Rice University bioengineer Gang Bao.
Bao, in collaboration with Baylor College of Medicine, Texas Children’s Hospital and Stanford University, is working to find a cure for the hereditary disease. A single DNA mutation causes the body to make sticky, crescent-shaped red blood cells that contain abnormal hemoglobin and can block blood flow in limbs and organs.
In his talk at the annual American Association for the Advancement of Science meeting in Austin Feb. 16, Bao revealed results from a series of tests to see whether CRISPR/Cas9-based editing can fix the mutation. His presentation was part of a scientific session titled “Gene Editing and Human Identity: Promising Advances and Ethical Challenges.”
“Sickle cell disease is caused by a single mutation in the beta-globin gene (in the stem cell’s DNA),” he said. “The idea is to correct that particular mutation, and then stem cells that have the correction would differentiate into normal blood cells, including red blood cells. Those will then be healthy blood cells.”
Bao’s lab collaborated with Vivien Sheehan, an assistant professor of pediatrics and hematology at Baylor and a member of the sickle cell program at Texas Children’s, to collect stem and progenitor cells (CD34-positive cells) from patients with the disease. These were then edited in the Bao lab with CRISPR/Cas9 together with a custom template, a piece of DNA designed to correct the mutation.
The gene-edited cells were injected into the bone marrow of immunodeficient mice and tested after 19 weeks to see how many retained the edit. “The rate of repair remained stable, which is great,” Bao said. This engraftment study was carried out in the lab of Matt Porteus, an associate professor of pediatrics at Stanford.
Another major finding of the study is that the CRISPR/Cas9 system could introduce large alterations to the genes in patients’ cells, in addition to small mutations or deletions. These off-target effects could cause a disease.
The findings, part of an upcoming paper, are a step toward treating sickle cell disease. Obstacles in the way of a cure include optimizing the CRISPR/Cas9 system to eliminate off-target effects, as well as finding a way to further increase the amount of gene-corrected stem cells.
Bao pointed out that researchers still don’t know whether repairing as much as 40 percent of the cells is enough to cure a patient. “We’d like to say, ‘Yes,’” he said, “but we don’t really know yet. That’s something we hope to learn from an eventual clinical trial.”
Learn more: Rice U. reports progress in pursuit of sickle cell cure
The Latest on: Sickle cell disease
[google_news title=”” keyword=”Sickle cell disease” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Sickle cell disease
- Sickle Cell and Hearing Losson April 19, 2024 at 5:01 pm
Sickle cell disease is a genetic blood disorder affecting red blood cells. It is characterized by the presence of abnormal haemoglobin, which causes red blood cells to take on a sickle-like shape, ...
- FDA's sickle cell therapy approval help Black Minnesotans dream of 'life without any restrictions'on April 18, 2024 at 9:05 am
Roughly 100,000 Americans, most of whom are Black, are living with sickle cell disease. The recent Food and Drug Administration approval of two new gene therapies brings the promise of a cure.
- New sickle cell treatment center opens at BJCon April 17, 2024 at 11:24 pm
One in 400 African Americans has sickle cell disease in Missouri. Now, the 12th sickle cell treatment center has been opened at BJC.
- Food is Medicine: Brooklyn And Sickle Cell Diseaseon April 16, 2024 at 9:13 am
Among the bustling streets that epitomize New York City's energy, thousands of residents are too sick to leave their homes. They grapple with diagnoses that severely impede their daily routines and ...
- Missouri, give sickle cell disease patients a better chance with new gene therapies | Opinionon April 16, 2024 at 3:08 am
Rosemary Britts’ daughter Ro lost her battle at the age of 29. The state should open up access to treatment options that could have helped her. | Opinion ...
- Missouri, give sickle cell disease patients a better chance with new gene therapies | Opinionon April 15, 2024 at 10:08 pm
Rosemary Britts’ daughter Ro lost her life to the disease when she was just 29. Photo courtesy of Rosemary Britts As a mother to a sickle cell disease patient, I’ve seen it all when it comes t ...
- Children With Sickle Cell Disease Experience Severe COVID-19 Infectionon April 15, 2024 at 7:48 am
In a registry-based analysis, more hospitalized children with SCD and COVID-19 had severe infection requiring supplemental oxygen, compared with the general population.
- Safety of a potential new treatment to manage complications from sickle cell diseaseon April 11, 2024 at 4:14 pm
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study. An early phase ...
- Researchers identify safety of a potential new treatment to manage complications from sickle cell diseaseon April 11, 2024 at 10:05 am
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study published in ...
- Medicare floats incentive for hospitals to offer new sickle cell treatmentson April 11, 2024 at 3:00 am
Hospitals within months could get extra federal money to administer pricey new gene therapies for sickle cell disease, including the first CRISPR-based treatment.
via Bing News